- Home
- PNRG vs EBS Comparison
PNRG vs EBS Comparison
Compare PNRG & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNRG | EBS |
|---|---|---|
| Founded | 1973 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.9M | 303.3M |
| IPO Year | 1995 | 2006 |
Fundamental Metrics
Financial Performance| Metric | PNRG | EBS |
|---|---|---|
| Price | $188.73 | $6.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 29.4K | ★ 1.1M |
| Earning Date | 11-18-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ 4.57 | N/A |
| Revenue | $189,052,000.00 | ★ $742,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | $41.60 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $133.40 | $4.36 |
| 52 Week High | $278.90 | $14.06 |
Technical Indicators
Market Signals| Indicator | PNRG | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 36.04 | 42.59 |
| Support Level | $178.37 | $5.50 |
| Resistance Level | $200.02 | $6.83 |
| Average True Range (ATR) | 8.73 | 0.46 |
| MACD | -3.94 | -0.09 |
| Stochastic Oscillator | 12.22 | 30.36 |
Price Performance
Historical ComparisonAbout PNRG PrimeEnergy Resources Corporation
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.